Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v16-FR | Version v16-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2024-04-10 | 2024-04-10 |
| Drug Identification Number | 02328925 | 02328925 |
| Brand name | THALLOUS CHLORIDE TI-201 INJECTION | THALLOUS CHLORIDE TI-201 INJECTION |
| Common or Proper name | thallous chloride Tl201 injection | thallous chloride Tl201 injection |
| Company Name | CURIUM CANADA INC | CURIUM CANADA INC |
| Ingredients | THALLIUM CHLORIDE | THALLIUM CHLORIDE |
| Strength(s) | 37MBq | 37MBq |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2.8 to 9.9 mCi | 2.8 to 9.9 mCi |
| ATC code | V09GX | V09GX |
| ATC description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2022-10-07 | 2022-10-07 |
| Actual start date | 2022-10-07 | 2022-10-07 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Following the discontinuation of Lantheus product, Curium is unable to cover lantheus market. Please also note that as of 28OCT20222, Curium will require maintenance on one of its cyclotron resulting in suspension of production for Curium Thallous Chloride injection during that period. | Following the discontinuation of Lantheus product, Curium is unable to cover lantheus market. Please also note that as of 28OCT20222, Curium will require maintenance on one of its cyclotron resulting in suspension of production for Curium Thallous Chloride injection during that period. |
| Health Canada comments |